1 | Acthar low dose (40 U) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 49 49 |
2 | Administration of a low dose of desipramine | 1件: Desipramine Desipramine | 1件: D07791
D07791
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 156 156 |
3 | Ambrisentan - low dose | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
4 | AXO-AAV-GM2 Low Dose | - | - | - | - | 1件: 19 19 |
5 | BI 655064 low dose | - | - | - | - | 1件: 46 46 |
6 | BIIL 284 BS low dose | - | - | - | - | 1件: 46 46 |
7 | BIIL 284 BS, low dose | - | - | - | - | 1件: 299 299 |
8 | BIIL 284 BS, low dose, adult patients | - | - | - | - | 1件: 299 299 |
9 | BIIL 284 BS, low dose, pediatric patients | - | - | - | - | 1件: 299 299 |
10 | BIRB 796 BS, low dose | - | - | - | - | 1件: 46 46 |
11 | BLI-1300 low dose | - | - | - | - | 1件: 96 96 |
12 | Brazikumab low dose | 1件: Brazikumab Brazikumab | 1件: D10912
D10912
| 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 |
13 | Clobazam Low Dose | 1件: Clobazam Clobazam | 1件: D01253
D01253
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 144 144 |
14 | CPL500036 - low dose | - | - | - | - | 1件: 6 6 |
15 | CVT-301 Low Dose | - | - | - | - | 1件: 6 6 |
16 | Cyclosporin, low dose steroid | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 |
17 | Elamipretide (low dose) | 1件: Elamipretide Elamipretide | 1件: D10925
D10925
| - | - | 1件: 21 21 |
18 | Enpatoran low dose | - | - | - | - | 1件: 49 49 |
19 | EUR-1008 (APT-1008) Low Dose | - | - | - | - | 1件: 298 298 |
20 | Fentanyl (Low Dose) | 1件: Fentanyl Fentanyl | 1件: D00320
D00320
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 215 215 |
21 | Fentanyl (Low Dose) + Dexmedetomidine | 2件: Dexmedetomidine Dexmedetomidine, Fentanyl | 2件: D00320
D00320
,
D00514
| 4件: ADRA2A ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 | 4件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
22 | GTX-102 low dose fast Period 1 and Period 2 | 1件: GTX-102 GTX-102 | - | - | - | 1件: 65 65 |
23 | HMPL-004 low dose | - | - | - | - | 1件: 97 97 |
24 | IgPro20 (low dose) | - | - | - | - | 1件: 14 14 |
25 | Iloprost low dose | 1件: Iloprost Iloprost | 1件: D02721
D02721
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 51 51 |
26 | Imsidolimab low dose | 1件: Imsidolimab Imsidolimab | 1件: D11892
D11892
| 1件: IL1RL2 IL1RL2 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 37 37 |
27 | KPS-0373, Low dose | - | - | - | - | 1件: 18 18 |
28 | KW-6356 Low Dose | 1件: KW-6356 KW-6356 | - | - | - | 1件: 6 6 |
29 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | 5件: Dapsone Dapsone, Mycophenolate mofetil, Mycophenolic acid, Prednisolone, Triamcinolone | 5件: D00385
D00385
,
D00472
,
D00592
,
D00752
,
D05096
| 3件: IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬 | 1件: 162 162 |
30 | LiRIS low dose and LiRIS high dose | - | - | - | - | 1件: 226 226 |
31 | Low dose | - | - | - | - | 1件: 97 97 |
32 | Low dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 6 6 |
33 | Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day | 1件: Vitamin D Vitamin D | - | - | - | 1件: 13 13 |
34 | Low Dose Aspirin (162 mg/day) | 1件: Acetylsalicylic acid Acetylsalicylic acid (Synonym: Low Dose Aspirin Enteric Safety-Coated) | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
35 | Low dose BIBF 1120 twice daily | - | - | - | - | 1件: 85 85 |
36 | Low dose BIBF1120 once daily | - | - | - | - | 1件: 85 85 |
37 | Low Dose Budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
38 | Low dose budesonide tablet | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
39 | Low dose cannabis | 1件: Medical Cannabis Medical Cannabis | - | - | - | 1件: 13 13 |
40 | Low dose levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
41 | Low dose LX2006 | - | - | - | - | 1件: 18 18 |
42 | Low Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | 1件: 49 49 |
43 | Low Dose MT-1303 | - | - | - | - | 1件: 97 97 |
44 | Low Dose MYOBLOC | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 |
45 | Low dose naltrexone | 1件: Naltrexone Naltrexone | 1件: D05113
D05113
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 96 96, 97 |
46 | Low dose of BIIL 284 BS tablets | - | - | - | - | 1件: 46 46 |
47 | Low dose ORTD-1 | - | - | - | - | 1件: 46 46 |
48 | Low dose prednisolone | 1件: Prednisolone Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
49 | Low dose TSO | - | - | - | - | 1件: 96 96 |
50 | Low dose vehicle control | - | - | - | - | 1件: 46 46 |
51 | Low Dose-VIS649 | - | - | - | - | 1件: 66 66 |
52 | LX3305 low dose | - | - | - | - | 1件: 46 46 |
53 | M5049 low dose | - | - | - | - | 1件: 49 49 |
54 | MEDI7183 low dose | - | - | - | - | 1件: 97 97 |
55 | MMX Mesalamine/Mesalazine (Low Dose) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
56 | MT-1303 Low dose | - | - | - | - | 1件: 49 49 |
57 | MT-7117 Low Dose | - | - | - | - | 1件: 254 254 |
58 | MultiStem low dose | 1件: MultiStem MultiStem | - | - | - | 1件: 97 97 |
59 | Mycophenolate mofetil, low dose steroid | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 2件: D00752
D00752
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 222 222 |
60 | OCU400 Low Dose | - | - | - | - | 1件: 90 90 |
61 | Orelabrutinib (Low Dose) | 1件: Orelabrutinib Orelabrutinib | 1件: D12160
D12160
| 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 49 49 |
62 | PF-06649751 low dose (1 mg QD) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
63 | PHA-022121 low dose | - | - | - | - | 1件: 65 65 |
64 | Prednisone, low dose rituximab | 2件: Prednisone Prednisone, Rituximab | 2件: D00473
D00473
,
D02994
| 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 |
65 | PXT3003 Low dose | - | - | - | - | 1件: 10 10 |
66 | Ravicti low dose | 1件: Glycerol phenylbutyrate Glycerol phenylbutyrate | 1件: D10127
D10127
| - | - | 1件: 299 299 |
67 | SA001 Low dose | - | - | - | - | 1件: 53 53 |
68 | SC0062 low dose | - | - | - | - | 1件: 66 66 |
69 | SEN0014196 (Low Dose) | - | - | - | - | 1件: 8 8 |
70 | TAS5315 low dose | - | - | - | - | 1件: 46 46 |
71 | Tiotropium bromide-low dose-2.5mcg | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
72 | Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) | 2件: Methylprednisolone Methylprednisolone, Ursodeoxycholic acid | 2件: D00407
D00407
,
D00734
| 2件: NR1H4 NR1H4, NR3C1 💬 | 2件: Bile secretion Bile secretion, Neuroactive ligand-receptor interaction 💬 | 1件: 93 93 |
73 | YRA-1909 low dose | - | - | - | - | 1件: 46 46 |